Point-Of-Care Or Rapid Diagnostics Industry Research Report 2023
Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
Highlights
The global Point-Of-Care Or Rapid Diagnostics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.
The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-Of-Care Or Rapid Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Point-Of-Care Or Rapid Diagnostics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Point-Of-Care Or Rapid Diagnostics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Point-Of-Care Or Rapid Diagnostics segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Point-Of-Care Or Rapid Diagnostics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Point-Of-Care Or Rapid Diagnostics market.
Point-Of-Care Or Rapid Diagnostics segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Point-Of-Care Or Rapid Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Point-Of-Care Or Rapid Diagnostics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-Of-Care Or Rapid Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-Of-Care Or Rapid Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
Highlights
The global Point-Of-Care Or Rapid Diagnostics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Or Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Or Rapid Diagnostics.
The Point-Of-Care Or Rapid Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-Of-Care Or Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point-Of-Care Or Rapid Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Roche
- Abbott
- Danaher
- Siemens Healthcare
- Bio-Rad Laboratories
- BioMerieux
- Nova Biomedical
- Thermo Fisher Scientific
- Quidel
- A. Menarini Diagnostics
- Becton Dickinson
- Biosurfit
- Astrego Diagnostics
- Werfen
- Abionic
- Palex Medical/Bьlhmann
- Horiba Medical
- RAL
- Vircell
- Monlab
- Binding Site
Global markets are presented by Point-Of-Care Or Rapid Diagnostics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Point-Of-Care Or Rapid Diagnostics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Point-Of-Care Or Rapid Diagnostics segment by Type
- Intensive Care
- Covid-19 Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Point-Of-Care Or Rapid Diagnostics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Point-Of-Care Or Rapid Diagnostics market.
Point-Of-Care Or Rapid Diagnostics segment by Application
- Hospital
- Clinic
- Independent Laboratories
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Point-Of-Care Or Rapid Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-Of-Care Or Rapid Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Point-Of-Care Or Rapid Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Point-Of-Care Or Rapid Diagnostics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-Of-Care Or Rapid Diagnostics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Point-Of-Care Or Rapid Diagnostics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Point-Of-Care Or Rapid Diagnostics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Point-Of-Care Or Rapid Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Point-Of-Care Or Rapid Diagnostics Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Manufacturers (2018-2023)
Table 7. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Point-Of-Care Or Rapid Diagnostics Revenue of Manufacturers (2018-2023)
Table 9. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Point-Of-Care Or Rapid Diagnostics Average Price (US$/Dose) of Manufacturers (2018-2023)
Table 11. Global Point-Of-Care Or Rapid Diagnostics Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-Of-Care Or Rapid Diagnostics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Roche Company Information
Table 17. Roche Business Overview
Table 18. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 19. Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 20. Roche Recent Developments
Table 21. Abbott Company Information
Table 22. Abbott Business Overview
Table 23. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 24. Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 25. Abbott Recent Developments
Table 26. Danaher Company Information
Table 27. Danaher Business Overview
Table 28. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 29. Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 30. Danaher Recent Developments
Table 31. Siemens Healthcare Company Information
Table 32. Siemens Healthcare Business Overview
Table 33. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 34. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 35. Siemens Healthcare Recent Developments
Table 36. Bio-Rad Laboratories Company Information
Table 37. Bio-Rad Laboratories Business Overview
Table 38. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 39. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 40. Bio-Rad Laboratories Recent Developments
Table 41. BioMerieux Company Information
Table 42. BioMerieux Business Overview
Table 43. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 44. BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 45. BioMerieux Recent Developments
Table 46. Nova Biomedical Company Information
Table 47. Nova Biomedical Business Overview
Table 48. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 49. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 50. Nova Biomedical Recent Developments
Table 51. Thermo Fisher Scientific Company Information
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 54. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 55. Thermo Fisher Scientific Recent Developments
Table 56. Quidel Company Information
Table 57. Quidel Business Overview
Table 58. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 59. Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 60. Quidel Recent Developments
Table 61. A. Menarini Diagnostics Company Information
Table 62. A. Menarini Diagnostics Business Overview
Table 63. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 64. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 65. A. Menarini Diagnostics Recent Developments
Table 66. Becton Dickinson Company Information
Table 67. Becton Dickinson Business Overview
Table 68. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 69. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 70. Becton Dickinson Recent Developments
Table 71. Biosurfit Company Information
Table 72. Biosurfit Business Overview
Table 73. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 74. Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 75. Biosurfit Recent Developments
Table 76. Astrego Diagnostics Company Information
Table 77. Astrego Diagnostics Business Overview
Table 78. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 79. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 80. Astrego Diagnostics Recent Developments
Table 81. Werfen Company Information
Table 82. Werfen Business Overview
Table 83. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 84. Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 85. Werfen Recent Developments
Table 86. Abionic Company Information
Table 87. Abionic Business Overview
Table 88. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 89. Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 90. Abionic Recent Developments
Table 91. Palex Medical/Bьlhmann Company Information
Table 92. Palex Medical/Bьlhmann Business Overview
Table 93. Palex Medical/Bьlhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 94. Palex Medical/Bьlhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 95. Palex Medical/Bьlhmann Recent Developments
Table 96. Horiba Medical Company Information
Table 97. Horiba Medical Business Overview
Table 98. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 99. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 100. Horiba Medical Recent Developments
Table 101. RAL Company Information
Table 102. RAL Business Overview
Table 103. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 104. RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 105. RAL Recent Developments
Table 106. Vircell Company Information
Table 107. Vircell Business Overview
Table 108. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 109. Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 110. Vircell Recent Developments
Table 111. Monlab Company Information
Table 112. Monlab Business Overview
Table 113. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 114. Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 115. Monlab Recent Developments
Table 116. Binding Site Company Information
Table 117. Binding Site Business Overview
Table 118. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 119. Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 120. Binding Site Recent Developments
Table 121. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2018-2023) & (K Doses)
Table 123. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2018-2023)
Table 124. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2024-2029) & (K Doses)
Table 125. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2024-2029)
Table 126. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2018-2023) & (US$ Million)
Table 127. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2018-2023)
Table 128. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2024-2029) & (US$ Million)
Table 129. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2024-2029)
Table 130. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 132. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 133. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 134. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 135. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 137. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 138. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 139. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 140. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 141. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 142. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 143. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 144. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 145. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 146. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 147. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 148. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 149. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 150. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 151. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 152. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 153. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 154. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 155. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses)
Table 156. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2024-2029) & (K Doses)
Table 157. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023)
Table 158. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2024-2029)
Table 159. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 160. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 161. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2023)
Table 162. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2024-2029)
Table 163. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2018-2023) & (US$/Dose)
Table 164. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2024-2029) & (US$/Dose)
Table 165. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses)
Table 166. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2024-2029) & (K Doses)
Table 167. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023)
Table 168. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2024-2029)
Table 169. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 170. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 171. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2023)
Table 172. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2024-2029)
Table 173. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2018-2023) & (US$/Dose)
Table 174. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2024-2029) & (US$/Dose)
Table 175. Key Raw Materials
Table 176. Raw Materials Key Suppliers
Table 177. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 178. Point-Of-Care Or Rapid Diagnostics Customers List
Table 179. Point-Of-Care Or Rapid Diagnostics Industry Trends
Table 180. Point-Of-Care Or Rapid Diagnostics Industry Drivers
Table 181. Point-Of-Care Or Rapid Diagnostics Industry Restraints
Table 182. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Point-Of-Care Or Rapid Diagnostics Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Point-Of-Care Or Rapid Diagnostics Sales (K Doses) of Manufacturers (2018-2023)
Table 7. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Point-Of-Care Or Rapid Diagnostics Revenue of Manufacturers (2018-2023)
Table 9. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Point-Of-Care Or Rapid Diagnostics Average Price (US$/Dose) of Manufacturers (2018-2023)
Table 11. Global Point-Of-Care Or Rapid Diagnostics Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-Of-Care Or Rapid Diagnostics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Roche Company Information
Table 17. Roche Business Overview
Table 18. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 19. Roche Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 20. Roche Recent Developments
Table 21. Abbott Company Information
Table 22. Abbott Business Overview
Table 23. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 24. Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 25. Abbott Recent Developments
Table 26. Danaher Company Information
Table 27. Danaher Business Overview
Table 28. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 29. Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 30. Danaher Recent Developments
Table 31. Siemens Healthcare Company Information
Table 32. Siemens Healthcare Business Overview
Table 33. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 34. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 35. Siemens Healthcare Recent Developments
Table 36. Bio-Rad Laboratories Company Information
Table 37. Bio-Rad Laboratories Business Overview
Table 38. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 39. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 40. Bio-Rad Laboratories Recent Developments
Table 41. BioMerieux Company Information
Table 42. BioMerieux Business Overview
Table 43. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 44. BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 45. BioMerieux Recent Developments
Table 46. Nova Biomedical Company Information
Table 47. Nova Biomedical Business Overview
Table 48. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 49. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 50. Nova Biomedical Recent Developments
Table 51. Thermo Fisher Scientific Company Information
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 54. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 55. Thermo Fisher Scientific Recent Developments
Table 56. Quidel Company Information
Table 57. Quidel Business Overview
Table 58. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 59. Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 60. Quidel Recent Developments
Table 61. A. Menarini Diagnostics Company Information
Table 62. A. Menarini Diagnostics Business Overview
Table 63. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 64. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 65. A. Menarini Diagnostics Recent Developments
Table 66. Becton Dickinson Company Information
Table 67. Becton Dickinson Business Overview
Table 68. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 69. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 70. Becton Dickinson Recent Developments
Table 71. Biosurfit Company Information
Table 72. Biosurfit Business Overview
Table 73. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 74. Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 75. Biosurfit Recent Developments
Table 76. Astrego Diagnostics Company Information
Table 77. Astrego Diagnostics Business Overview
Table 78. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 79. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 80. Astrego Diagnostics Recent Developments
Table 81. Werfen Company Information
Table 82. Werfen Business Overview
Table 83. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 84. Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 85. Werfen Recent Developments
Table 86. Abionic Company Information
Table 87. Abionic Business Overview
Table 88. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 89. Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 90. Abionic Recent Developments
Table 91. Palex Medical/Bьlhmann Company Information
Table 92. Palex Medical/Bьlhmann Business Overview
Table 93. Palex Medical/Bьlhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 94. Palex Medical/Bьlhmann Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 95. Palex Medical/Bьlhmann Recent Developments
Table 96. Horiba Medical Company Information
Table 97. Horiba Medical Business Overview
Table 98. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 99. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 100. Horiba Medical Recent Developments
Table 101. RAL Company Information
Table 102. RAL Business Overview
Table 103. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 104. RAL Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 105. RAL Recent Developments
Table 106. Vircell Company Information
Table 107. Vircell Business Overview
Table 108. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 109. Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 110. Vircell Recent Developments
Table 111. Monlab Company Information
Table 112. Monlab Business Overview
Table 113. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 114. Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 115. Monlab Recent Developments
Table 116. Binding Site Company Information
Table 117. Binding Site Business Overview
Table 118. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 119. Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolio
Table 120. Binding Site Recent Developments
Table 121. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2018-2023) & (K Doses)
Table 123. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2018-2023)
Table 124. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2024-2029) & (K Doses)
Table 125. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2024-2029)
Table 126. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2018-2023) & (US$ Million)
Table 127. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2018-2023)
Table 128. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2024-2029) & (US$ Million)
Table 129. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2024-2029)
Table 130. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 132. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 133. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 134. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 135. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 137. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 138. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 139. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 140. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 141. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 142. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 143. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 144. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 145. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 146. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 147. Latin America Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 148. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 149. Latin America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 150. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 151. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses)
Table 152. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2024-2029) & (K Doses)
Table 153. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & (US$ Million)
Table 154. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2024-2029) & (US$ Million)
Table 155. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses)
Table 156. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2024-2029) & (K Doses)
Table 157. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023)
Table 158. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2024-2029)
Table 159. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2018-2023) & (US$ Million)
Table 160. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2024-2029) & (US$ Million)
Table 161. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2023)
Table 162. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2024-2029)
Table 163. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2018-2023) & (US$/Dose)
Table 164. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2024-2029) & (US$/Dose)
Table 165. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses)
Table 166. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2024-2029) & (K Doses)
Table 167. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023)
Table 168. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2024-2029)
Table 169. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2018-2023) & (US$ Million)
Table 170. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2024-2029) & (US$ Million)
Table 171. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2023)
Table 172. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2024-2029)
Table 173. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2018-2023) & (US$/Dose)
Table 174. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2024-2029) & (US$/Dose)
Table 175. Key Raw Materials
Table 176. Raw Materials Key Suppliers
Table 177. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 178. Point-Of-Care Or Rapid Diagnostics Customers List
Table 179. Point-Of-Care Or Rapid Diagnostics Industry Trends
Table 180. Point-Of-Care Or Rapid Diagnostics Industry Drivers
Table 181. Point-Of-Care Or Rapid Diagnostics Industry Restraints
Table 182. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Point-Of-Care Or Rapid DiagnosticsProduct Picture
Figure 5. Global Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Point-Of-Care Or Rapid Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 7. Global Point-Of-Care Or Rapid Diagnostics Sales (2018-2029) & (K Doses)
Figure 8. Global Point-Of-Care Or Rapid Diagnostics Average Price (US$/Dose) & (2018-2029)
Figure 9. Intensive Care Product Picture
Figure 10. Covid-19 Testing Product Picture
Figure 11. Infectious Diseases Testing Product Picture
Figure 12. Cardiac Markers Testing Product Picture
Figure 13. Coagulation Testing Product Picture
Figure 14. Others Product Picture
Figure 15. Hospital Product Picture
Figure 16. Clinic Product Picture
Figure 17. Independent Laboratories Product Picture
Figure 18. Others Product Picture
Figure 19. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers in 2022
Figure 20. Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Sites & Headquarters
Figure 21. Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue in 2022
Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. Global Point-Of-Care Or Rapid Diagnostics Sales by Region in 2022
Figure 26. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region in 2022
Figure 27. North America Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 28. North America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 29. North America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 30. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 33. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 34. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 35. Germany Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. France Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. U.K. Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Italy Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Russia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 41. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 42. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 43. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Japan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. South Korea Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. India Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Australia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. China Taiwan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Indonesia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Thailand Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Malaysia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 53. Latin America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 54. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 55. Mexico Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Brazil Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Argentina Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 59. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 60. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 61. Turkey Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. Saudi Arabia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 63. UAE Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2029)
Figure 65. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2029)
Figure 66. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Type (2018-2029)
Figure 67. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2029)
Figure 68. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2029)
Figure 69. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Application (2018-2029)
Figure 70. Point-Of-Care Or Rapid Diagnostics Value Chain
Figure 71. Point-Of-Care Or Rapid Diagnostics Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Point-Of-Care Or Rapid DiagnosticsProduct Picture
Figure 5. Global Point-Of-Care Or Rapid Diagnostics Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Point-Of-Care Or Rapid Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 7. Global Point-Of-Care Or Rapid Diagnostics Sales (2018-2029) & (K Doses)
Figure 8. Global Point-Of-Care Or Rapid Diagnostics Average Price (US$/Dose) & (2018-2029)
Figure 9. Intensive Care Product Picture
Figure 10. Covid-19 Testing Product Picture
Figure 11. Infectious Diseases Testing Product Picture
Figure 12. Cardiac Markers Testing Product Picture
Figure 13. Coagulation Testing Product Picture
Figure 14. Others Product Picture
Figure 15. Hospital Product Picture
Figure 16. Clinic Product Picture
Figure 17. Independent Laboratories Product Picture
Figure 18. Others Product Picture
Figure 19. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturers in 2022
Figure 20. Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Sites & Headquarters
Figure 21. Global Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Point-Of-Care Or Rapid Diagnostics Players Market Share by Revenue in 2022
Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Global Point-Of-Care Or Rapid Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. Global Point-Of-Care Or Rapid Diagnostics Sales by Region in 2022
Figure 26. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region in 2022
Figure 27. North America Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 28. North America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 29. North America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 30. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 33. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 34. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 35. Germany Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. France Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. U.K. Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Italy Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Russia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Asia Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 41. Asia Pacific Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 42. Asia Pacific Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 43. China Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Japan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. South Korea Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. India Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Australia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. China Taiwan Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Indonesia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Thailand Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Malaysia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Latin America Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 53. Latin America Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 54. Latin America Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 55. Mexico Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Brazil Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Argentina Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country in 2022
Figure 59. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2029)
Figure 60. Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2029)
Figure 61. Turkey Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. Saudi Arabia Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 63. UAE Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2029)
Figure 65. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2029)
Figure 66. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Type (2018-2029)
Figure 67. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2029)
Figure 68. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2029)
Figure 69. Global Point-Of-Care Or Rapid Diagnostics Price (US$/Dose) by Application (2018-2029)
Figure 70. Point-Of-Care Or Rapid Diagnostics Value Chain
Figure 71. Point-Of-Care Or Rapid Diagnostics Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Point-Of-Care Or Rapid Diagnostics Industry Opportunities and Challenges
